Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 14, 2020 - Issue 8
Submit an article Journal homepage
267
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma

Chuan Lia Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, ChinaView further author information
,
Zhi-Cheng Lia Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, ChinaView further author information
,
Liang Maa Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;b Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, ChinaView further author information
,
Le-Qun Lia Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;b Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, ChinaView further author information
,
Jian-Hong Zhonga Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;b Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, ChinaORCID Iconhttps://orcid.org/0000-0002-1494-6396View further author information
ORCID Icon,
Bang-De Xianga Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;b Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, ChinaView further author information
&
Wen-Feng Gonga Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;b Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 749-756 | Received 27 Mar 2020, Accepted 16 Jun 2020, Published online: 30 Jun 2020

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229(6):790–799; discussion 799–800.
  • Yin J, Li N, Han Y, et al. Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study. J Clin Oncol. 2013;31(29):3647–3655.
  • Huang G, Li PP, Lau WY, et al. Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: a randomized controlled trial. Ann Surg. 2018;268(6):943–954.
  • Huang G, Lau WY, Wang ZG, et al. Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial. Ann Surg. 2015;261(1):56–66.
  • Sarin SK, Kumar M, Lau GK, et al.. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98.
  • Martin P, Lau DT, Nguyen MH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2015 update. Clin Gastroenterol Hepatol. 2015;13(12):2071–2087e2016.
  • Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599.
  • Gong WF, Zhong JH, Lu SD, et al. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma. Oncotarget. 2017;8(9):15047–15056.
  • Liu XF, Zhang T, Tang K, et al. Study of Preoperative Antiviral Treatment of Patients with HCC Negative for HBV-DNA. Anticancer Res. 2017;37(8):4701–4706.
  • Chen P, Yu C, Wu W, et al Serolological profile among hbsag-positive infections in Southeast China: a community-based study. Hepatitis Mon. 2013;13(1):e7604.
  • Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–1325.
  • Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis. 2011;15(4):685–698.
  • Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006;354(10):1011–1020.
  • Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354(10):1001–1010.
  • Zhong J-H, Ma L, Li L-Q. Postoperative antiviral therapy with Nucleos(t)ide analogs in patients with hepatitis B virus–related hepatocellular carcinoma. Ann Surg. 2017;265(4):e46–e47.
  • Hoofnagle JH. Reactivation of hepatitis B. Hepatology. 2009;49(5 Suppl):S156–165.
  • Lao X-M, Luo G, Ye L-T. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma. Liver Int. 2013;33(4):595–604.
  • Loomba R, Liang TJ. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology. 2017;152(6):1297–1309.
  • Xu M, Zhou Z, Xu R, et al. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis. World J Surg Oncol. 2019;17(1):45.
  • Hsu CS. Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence. JAMA. 2013;309(8):765–766.
  • Qu LS, Jin F, Huang XW, et al. High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection. J Gastrointest Surg. 2010;14(7):1111–1120.
  • Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology. 1990;12(1):59–65.
  • Shanshan W, Xinfang D, Shuihong Y, et al. Pathological changes of liver one year later in CHB patients with negative HBV DNA. Infect Agent Cancer. 2019;14:48.
  • Gong WF, Zhong JH, Lu Z, et al. Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Biosci Rep. 2019;39(8). DOI:10.1042/BSR20190088

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.